Related Experiment Video

Updated: Jul 2, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

[Indications and optimal terms of liver transplantation in chronic diffuse hepatic disease]

O I Malomuzh, P E Krel', S V Got'e

    Klinicheskaia Meditsina
    |August 30, 2008
    PubMed

    Insights

    Liver transplantation is crucial for patients with chronic diffuse hepatic disease and hepatic cirrhosis. Early intervention, especially for inborn metabolism disturbances, improves patient outcomes and quality of life.

    Area of Science:

    • Hepatology
    • Transplant Surgery

    Context:

    • Chronic diffuse hepatic disease (CDHD) significantly impacts adult morbidity.
    • Hepatic cirrhosis (HC) presents a major treatment challenge.
    • Liver transplantation is a key treatment for end-stage liver disease.

    Purpose:

    • To highlight the importance of liver transplantation in managing hepatic cirrhosis and other severe liver conditions.
    • To emphasize the trend towards early transplantation before major organ decompensation.

    Summary:

    • Orthotopic liver transplantation (OTH) is indicated for various etiologies including hepatic cirrhosis, cholestatic diseases, inborn metabolism disturbances, and hepatic tumors.
    • For inborn metabolism disturbances, OTH is performed concurrently with diagnosis.
    • The urgency for OTH in hepatic cirrhosis is determined by disease stage (Child-Pugh, MELD scores), treatment response, and hospitalization frequency.

    Impact:

    • Liver transplantation significantly prolongs patient survival.
    • The procedure substantially enhances the quality of life for patients with severe liver disease.

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
    Kidney Transplant I: Introduction01:28

    Kidney Transplant I: Introduction

    A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
    Chronic Bowel Disorders: Introduction01:17

    Chronic Bowel Disorders: Introduction

    Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
    Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...